4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

C44H66N2O5 — CID 163475467

IUPAC4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)[C@@H]1CC[C@]2(CNCCC(=O)NC(C)(CO)CO)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CC[C@]43C)[C@@H]12
InChIInChI=1S/C44H66N2O5/c1-28(2)31-15-21-44(25-45-24-18-36(49)46-40(5,26-47)27-48)23-22-42(7)33(37(31)44)13-14-35-41(6)19-16-32(29-9-11-30(12-10-29)38(50)51)39(3,4)34(41)17-20-43(35,42)8/h9-12,16,31,33-35,37,45,47-48H,1,13-15,17-27H2,2-8H3,(H,46,49)(H,50,51)/t31-,33+,34?,35?,37+,41-,42+,43+,44+/m0/s1
InChIKeyBZZYMGPTKJCCBV-QKLRSZKXSA-N
MW703.02 g/mol
LogP7.87
Rot. Bonds11

About 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 163475467) has the molecular formula C44H66N2O5 and a molecular weight of 703.02 g/mol. Its IUPAC name is 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID163475467
Molecular FormulaC44H66N2O5
Molecular Weight703.02 g/mol
Exact Mass702.50
IUPAC Name4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)[C@@H]1CC[C@]2(CNCCC(=O)NC(C)(CO)CO)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CC[C@]43C)[C@@H]12
InChIInChI=1S/C44H66N2O5/c1-28(2)31-15-21-44(25-45-24-18-36(49)46-40(5,26-47)27-48)23-22-42(7)33(37(31)44)13-14-35-41(6)19-16-32(29-9-11-30(12-10-29)38(50)51)39(3,4)34(41)17-20-43(35,42)8/h9-12,16,31,33-35,37,45,47-48H,1,13-15,17-27H2,2-8H3,(H,46,49)(H,50,51)/t31-,33+,34?,35?,37+,41-,42+,43+,44+/m0/s1
InChIKeyBZZYMGPTKJCCBV-QKLRSZKXSA-N
XLogP7.87
TPSA118.89 Ų
H-Bond Donors5
H-Bond Acceptors5
Rotatable Bonds11
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500703.02
LogP ≤ 57.87
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (CID 163475467) is 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is C=C(C)[C@@H]1CC[C@]2(CNCCC(=O)NC(C)(CO)CO)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CC[C@]43C)[C@@H]12.
What is the InChIKey of 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is BZZYMGPTKJCCBV-QKLRSZKXSA-N. The full InChI is InChI=1S/C44H66N2O5/c1-28(2)31-15-21-44(25-45-24-18-36(49)46-40(5,26-47)27-48)23-22-42(7)33(37(31)44)13-14-35-41(6)19-16-32(29-9-11-30(12-10-29)38(50)51)39(3,4)34(41)17-20-43(35,42)8/h9-12,16,31,33-35,37,45,47-48H,1,13-15,17-27H2,2-8H3,(H,46,49)(H,50,51)/t31-,33+,34?,35?,37+,41-,42+,43+,44+/m0/s1.
What are the key properties of 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 703.02 g/mol, XLogP of 7.87, 11 rotatable bonds, 5 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(1R,3aS,5aR,5bR,11aS,13aR,13bR)-3a-[[[3-[(1,3-dihydroxy-2-methylpropan-2-yl)amino]-3-oxopropyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 163475467), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).